+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endothelial barrier function after phacoemulsification: a comparison between diabetic and non-diabetic patients

Endothelial barrier function after phacoemulsification: a comparison between diabetic and non-diabetic patients

Graefe's Archive for Clinical and Experimental Ophthalmology 229(3): 254-257

In all, 21 diabetic and 23 non-diabetic patients underwent endothelial fluorophotometry before and at 4 days, 3 weeks and 6 weeks after phacoemulsification with posterior chamber intraocular lens (IOL: PMMA) implantation. After topical fluorescein instillation, fluorophotometry was performed using an automated computerized fluorophotometer. The aim of this study was to assess early postoperative endothelial damage quantitatively and to detect possible differences between diabetic and non-diabetic patients in that regard. Preoperatively, the endothelial permeability of diabetic patients did not differ from that of non-diabetic individuals (P = 0.5). At 4 days after phacoemulsification with posterior chamber IOL implantation, endothelial permeability was significantly increased in both groups (P less than 0.001), but significantly more so in diabetic patients (P less than 0.001). The endothelial barrier function had fully recovered 3 weeks after surgery in non-diabetic subjects and 6 weeks after surgery in diabetic patients as well.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040019336

Download citation: RISBibTeXText

PMID: 1869062

DOI: 10.1007/bf00167879

Related references

Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye 18(9): 900-904, 2004

Corneal endothelial evaluation of diabetic patients after phacoemulsification. Journal Francais d'Ophtalmologie 42(4): 381-386, 2019

Endothelial function in offspring of Type 1 diabetic patients with and without diabetic nephropathy. Diabetic Medicine 16(4): 298-303, 1999

Persistently impaired endothelial function in type 2 diabetic patients, but not in non-diabetic patients, after acute myocardial infarction. Diabetologia 46(Suppl. 2): A 413, 2003

Endothelial function and left ventricular remodeling in diabetic and non-diabetic patients after acute coronary syndrome. Medical Science Monitor 17(2): Cr73-Cr77, 2011

Amadori-albumin in type I diabetic patients correlates with markers of endothelial function and associates with diabetic nephropathy. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 547A, 1999

Relationship between diabetic retinopathy and vascular endothelial function in elderly type 2 diabetic Japanese patients without cardiovascular disease. Geriatrics & Gerontology International 7(4): 348-351, 2007

Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients. Clinical Endocrinology 80(2): 228-234, 2014

Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 48(12): 2446-2453, 1999

Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -. Circulation Journal 74(7): 1471-1478, 2010

Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non-diabetic and diabetic patients. Clinical and Experimental Ophthalmology 34(6): 526-534, 2006

Progression of diabetic retinopathy after phacoemulsification in diabetic patients: a three-year analysis. Chang Gung Medical Journal 26(11): 829-834, 2003

Visual outcome after phacoemulsification with lens implant in diabetic and non-diabetic patients; A comparative study. Pakistan Journal of Medical Sciences 33(3): 691-694, 2017

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema. Journal of Ophthalmology 2017: 4896036, 2017

Comparison of left ventricle structure and function in diabetic and non-diabetic patients treated with peritoneal dialysis. Nephrology Dialysis Transplantation 14(9): A246, 1999